Document:

Exhibit 10.2
                            TRANSITION AGREEMENT

       THIS TRANSITION AGREEMENT (this "Agreement") is entered into as
of April 22, 2008, by and between VSE Corporation, a Delaware
corporation (the "Company" or "VSE"), and Donald M. Ervine ("Mr.
Ervine"), an individual currently residing in Fairfax, Virginia.

                                  RECITALS:
                                  ---------

       R. 1.	Mr. Ervine is currently employed as the Chairman of VSE's
board of directors (the "Board"), and VSE's Chief Executive Officer,
President and Chief Operating officer, pursuant to an Employment
Agreement dated as of October 21, 1998 between VSE and Mr. Ervine (the
"Ervine Employment Agreement").

       R. 2.	As of the date hereof, the Company entered into an
Employment Agreement with Maurice A. Gauthier pursuant to which the
Company has agreed to employ Maurice A. Gauthier commencing as of April
28, 2008 as VSE's Chief Executive Officer ("VSE's CEO"), President and
Chief Operating Officer.

       R. 3.	As of April 28, 2008, Mr. Ervine will be deemed for all
purposes to have resigned as VSE's CEO, President and Chief Operating
Officer.

       R. 4.	The Company desires to benefit from the experience and
ability of Mr. Ervine arising from his prior senior positions with VSE
by engaging Mr. Ervine, subject to his election as a director of VSE,
to serve as a Chairman of the Board ("Chairman") and he is willing to
serve as Chairman upon the terms and conditions contained herein.

       R. 5.	In recognition of Mr. Ervine's 25 years of loyal and
dedicated service to VSE and VSE's shareholders, the Board is awarding
Mr. Ervine, pursuant to VSE's 2006 Restricted Stock Plan, 4,374 shares
of VSE common stock, par value $0.05 per share, on the occasion of Mr.
Ervine's resignation as VSE's CEO, President and Chief Operating
Officer.  During the period from 2001 to 2007 VSE's management team,
led by Mr. Ervine, achieved on VSE's behalf exceptional growth in
revenues, net income and market capitalization.  For 2001, VSE had
revenues of $111.6 million and net income of $855,000 and as of
December 31, 2001, VSE had a market capitalization of approximately
$29.5 million.  For 2007 VSE had annual revenues of at least $653
million, net income of approximately $14 million, and as of December
31, 2007, VSE had a market capitalization of approximately $238.3
million (more than eight times VSE's market capitalization as of
December 31, 2001).

       NOW, THEREFORE, in consideration of the mutual promises,
covenants, and undertakings contained in this Agreement, the Company
and Mr. Ervine hereby agree as follows:

1.	Resignation.  Effective as of April 28, 2008, Mr. Ervine is
hereby resigning as VSE's CEO, President and Chief Operating Officer.
Subject to Section 8, Mr. Ervine will continue to serve hereunder as

Chairman in an executive capacity as contemplated by Article V, Section
1 of VSE's bylaws ("Executive Chairman") from April 28, 2008 to
December 31, 2008.  Subject to Section 8, from January 1, 2009 to
December 31, 2010, Mr. Ervine will serve hereunder as Chairman, without
being either an executive or employee of VSE ("Non-Executive
Chairman").

2.	Term.  As used herein, "Term" means the two periods referenced in
Section 1 during which Mr. Ervine will serve first as Executive
Chairman and then as Non-Executive Chairman hereunder, subject to
earlier termination as provided in Section 8.

3.	Services.

       (a)	General.  During the Term, Mr. Ervine shall, during the
Company's normal business hours and upon reasonable notice, make
himself available to perform such mentoring, consulting and advisory
services as are reasonably requested by the Board or VSE's CEO and are
reasonably consistent with Mr. Ervine's experience, background and
current and former positions with the Company.  Mr. Ervine acknowledges
and agrees that with reasonable notice he shall make himself available
for such mentoring, consulting and advisory services.  In providing
such services, Mr. Ervine shall endeavor to do so in a professional and
diligent manner, providing the Company, its subsidiaries, and
management of the Company and its subsidiaries with the benefits of his
informed and professional judgment.  Mr. Ervine agrees to attend such
meetings as the Company may reasonably request for proper communication
of his advice and consultation.  Mr. Ervine shall coordinate the
furnishing of his services pursuant to this Agreement with Company
representatives so that such services can be provided in a manner as to
generally conform to the Company's business schedules, but the method
of performance, time of performance, place of performance, hours
utilized in such performance, and other details of the manner of
performance of Mr. Ervine's services hereunder shall be within Mr.
Ervine's sole control and discretion.  While retained as Non-Executive
Chairman hereunder, Mr. Ervine shall have the right to devote his
business day and working efforts to other business, professional,
public service, or community pursuits as do not materially interfere or
conflict (as determined by mutual agreement of the Company and Mr.
Ervine) with the rendering of consulting services to the Company
hereunder.

       (b)	Related Services.  In addition, during the Term Mr. Ervine
will provide mentoring, consulting and advisory services to VSE's CEO
in the following areas:

	-	Shareholders' Advocate

	-	Corporate Governance, Oversight (including
		internal/external audits) and Legal Compliance

	-	Quality Management System/Information Technology System

	-	Sustainment of the corporate culture for honesty, integrity
		and quality work in all business dealings

                                     -2-

		-	Strategic Planning

		-	Business Plan (marketing and business development)

		-	Corporate Financial Planning

		-	Mergers and Acquisitions

		-	Succession Planning (all levels)

		-	Banking Relationships

		-	Customer Relations (work performance)

		-	Investor Relations(public trading market)

		-	Facilities/Infrastructure and Relocation Planning

		-	Advocate for Continued Growth and Profitability

       (c)	Additional Services.  During the Term when Mr. Ervine is
serving as Chairman, he shall also continue to perform the following
currently assigned duties:

		-	Chairman of the Board of Directors of VSE's subsidiary
			Energetics Incorporated

		-	Chairman of the Board of Directors of VSE's subsidiary
			Integrated Concepts and Research Corporation

		-	Chairman of VSE Planning and Finance Committee

4.	Support Facilities.  During the Term, the Company shall provide
Mr. Ervine with appropriate office space, secretarial support,
telephone (including cell phone) and computer support.

5.	Compensation, Benefits and Reimbursement.

       (a)	Executive Chairman.

              (i)	During the Term from April 28, 2008 to December 31,
2008, Mr. Ervine's current base salary at the rate of $360,000 per
annum will remain payable to Mr. Ervine as Executive Chairman or, as
the case may be, as a director of VSE ("VSE director").  In the event
of Mr. Ervine's death or disability before January 1, 2009, any unpaid
balance of Mr. Ervine's salary for the balance of the Term as if it had
expired on December 31, 2008 will be immediately payable in a lump sum
to Mr. Ervine's surviving spouse or his estate.

                                     -3-

              (ii)	In respect of VSE's fiscal year ending December 31,
2008, Mr. Ervine will remain a participant in VSE's 2006 Restricted
Stock Plan, Performance Bonus Plan and Deferred Supplemental
Compensation Plan at his current salary base of $360,000 per annum and
will be eligible for restricted stock awards and performance bonus for
VSE's fiscal year 2008 that will be awarded during the three-month
period ending on March 31, 2009.  Mr. Ervine's participation,
eligibility and related rights and benefits set forth above in this
Section 5(a)(ii) shall not be adversely affected by Mr. Ervine not
being a VSE employee, whether hereunder or otherwise, after December
31, 2008.

              (iii)	VSE shall withhold from Mr. Ervine's compensation
hereunder and pay over to the appropriate governmental agencies all
payroll taxes, including income, social security, and unemployment
compensation taxes, required by the federal, state and local
governments with jurisdiction over VSE.

              (iv)	While serving hereunder during the Term from April
28, 2008 to December 31, 2008, Mr. Ervine shall be entitled to such
vacation benefits and comparable fringe benefits and perquisites as may
be provided generally to VSE's senior officers pursuant to policies
established from time to time by VSE.  These fringe benefits and
perquisites may include holidays, group health insurance, short-term
and long-term disability insurance, life insurance, and retirement plan
contributions.

       (b)	Non-Executive Chairman.  During the Term from January 1,
2009 to December 31, 2010:

              (i)	Mr. Ervine's compensation as Non-Executive Chairman
or, as the case may be, as a VSE director and for his other duties and
responsibilities hereunder will be at the rate of $216,000 per annum,
payable on the last day of each calendar month;

              (ii)	Mr. Ervine shall pay all social security, federal
income taxes, unemployment insurance, worker's compensation insurance,
pensions, or other liabilities or taxes incurred by or on behalf or for
the benefit of him arising out of the performance of his obligations
hereunder;

              (iii)	Mr. Ervine shall not be entitled to participate in
the Company's or its subsidiaries' benefit plans and programs for their
employees except for VSE's dental program for which he will be required
to pay the Company the required fee for this service; and

              (iv)	Mr. Ervine will be considered to have retired as an
officer and employee of VSE as of the close of business on December 31,
2008, and thereafter Mr. Ervine will not be considered to be an
employee, agent or servant of the Company or of any of its
subsidiaries; and except as may be otherwise approved by the Board, Mr.
Ervine, when acting hereunder, shall have no authority to bind the
Company or any of its subsidiaries in any capacity for any purpose.

       (c)	No Other Compensation.  Except as set forth herein, no
other compensation or fees, including compensation for services as a
non-employee director, shall be payable to Mr. Ervine for services

                                     -4-

performed hereunder in his capacity as Executive Chairman or, as the
case may be, a VSE director from April 28, 2008 to December 31, 2008
and as Non-Executive Chairman or, as the case may be, a VSE director
from January 1, 2009 to December 31, 2010.  By example, during the
Term, Mr. Ervine shall not be entitled (i) to participate in VSE's 2004
Director Stock Plan, (ii) to receive restricted stock awards as a non-
employee director, (iii) to receive fees as a non-employee director nor
as a non-employee Chairman, or (iv) to receive fees for attending
meetings of the Board or standing or special committees of the Board.

       (d)	Reimbursement.  The Company shall reimburse Mr. Ervine for
all reasonable out-of-pocket expenses that are actually incurred by him
in performance of his duties hereunder during the Term, including
transportation, hotel accommodations and such other expenses as might
be incurred by a senior executive of the Company in furtherance of
Company business.  Before the last day of the month following each
month of the Term when reimbursable expenses are incurred, Mr. Ervine
shall submit to the Company a monthly statement setting forth the
reimbursable expenses incurred for the prior month.  With such
statements, Mr. Ervine shall furnish all records, receipts and other
evidence in support of his reimbursable expense statement as may be
requested by the Company according to its policy in effect for employee
expense reports.  Upon receipt of the expense statements, the Company
shall promptly reimburse Mr. Ervine for his expenses.

       (e)	Retirement.  Upon Mr. Ervine's retirement as an officer and
employee of VSE, as contemplated hereby, as of the close of business on
December 31, 2008, Mr. Ervine shall be entitled to receive from VSE all
retirement benefits to which a retiring officer and employee of VSE
would be entitled from VSE, including as a participant under VSE's
Deferred Supplemental Compensation Plan.

6.	Performance Incentive.  During the Term, Mr. Ervine will assist
VSE's CEO in promoting VSE's continued growth and profitability.  If
VSE achieves a 29% ROE (return on equity) for 2009 or a 31% ROE for
2010, as determined by VSE's chief financial officer and approved by
the Board, the Company will pay Mr. Ervine an incentive bonus not to
exceed $216,000 for 2009 or 2010, after public announcement of VSE's
audited financial results for such year.  Any determination of the
specific amount of Mr. Ervine's incentive bonus, if any, shall be made
by the Board's compensation committee and the Board.

7.	Confidential Information.  Mr. Ervine hereby agrees that
notwithstanding any other provision hereof, he will not at any time
make any unauthorized disclosure of any confidential business
information or trade secrets of the Company (which he acknowledges are
valuable and unique assets of the Company used in its business to
obtain a competitive advantage over the Company's competitors who do
not know or use this information), or make any unauthorized use
thereof; provided, however, this restriction shall not apply to any
information that has entered the public domain (other than by his own
acts or omissions).  The obligations of Mr. Ervine set forth in this
Section 7 shall apply during the Term and shall survive termination of
the Term or the termination of Mr. Ervine's services under this
Agreement regardless of the reason for such termination for a period of

                                     -5-

365 consecutive days following such termination.  For purposes of this
Section 7, the Company shall be construed to include any subsidiary or
other affiliate of the Company.

8.	Nomination as a Director, Appointment as Chairman and Termination
of the Term.

       (a)	Nomination as a Director and Appointment as Chairman.
During the Term, the Board will, subject to applicable laws and
regulations and the Board's fiduciary duties to the Company and its
stockholders: (i) nominate Mr. Ervine to be elected as a VSE director
by VSE's stockholders at each annual and other meeting of VSE's
stockholders at which they will elect VSE directors and (ii) if Mr.
Ervine is then a VSE director, appoint and maintain Mr. Ervine as
Chairman  during the period commencing on April 28, 2008 and continuing
until at least the date of the first  annual or other meeting of VSE's
stockholders in 2010 at which they  will elect VSE directors.

       (b)	Ceases being Chairman.  Notwithstanding anything herein to
the contrary, if during the Term Mr. Ervine ceases being Chairman but
is a VSE director, (i) Mr. Ervine's obligations set forth in Sections
3, 6 and 7 shall continue for the balance of the Term, (ii)  VSE's
obligations set forth in Sections 4, 5 and 6 shall continue as
otherwise provided therein; and (iii) clauses (b) and (c) of this
Section 8 and Sections 9 through and including 17 shall continue in
full force and effect.

       (c)	Termination of the Term.  Notwithstanding anything herein
to the contrary, the Term shall terminate upon the earlier of:  (i) Mr.
Ervine ceasing to be a VSE director for any reason, including the
expiration of his term as a VSE director or the failure of VSE's
stockholders to elect Mr. Ervine as a VSE director, or Mr. Ervine's
death or disability, (ii) notice provided to Mr. Ervine by VSE on or
after December 31, 2008 of VSE's termination of the Term or (iii)
expiration of the Term as of December 31, 2010.  Upon any termination
of the Term before December 31, 2010, except as may be specifically
otherwise provided herein, no compensation, fees or benefits shall
continue thereafter to accrue for the benefit of, or otherwise be
provided to, Mr. Ervine, or his surviving spouse or estate.  If,
however, the Company elects, pursuant to clause (ii) of the immediately
preceding sentence, to terminate the Term before December 31, 2010, VSE
shall within 30 days thereafter pay to Mr. Ervine (or, in the event of
his death after such termination, to his surviving spouse or estate), a
lump sum equal to the compensation and fees Mr. Ervine would have
earned under Section 5(b)(i), if Mr. Ervine had continued to serve
hereunder until December 31, 2010.

9.	Notices.  For purposes of this Agreement, notices, demands,
consents, waivers, approvals and all other communications provided for
in or otherwise contemplated by this Agreement shall be in writing and
shall be deemed to have been duly given when delivered by hand at, or
by sending the same by prepaid first class mail (airmail if to an
address outside the country of posting) to, the following addresses:

                                     -6-

	Donald M. Ervine
	9802 Dansk Court
	Fairfax, VA 22032

If to the Company:

	VSE Corporation
	2550 Huntington Avenue
	Alexandria, VA  22203-1499
	Attention:  Chief Executive Officer

or to such other address as either party may furnish to the other in
writing in accordance herewith, except that notices of change of
address shall be effective only upon receipt.

10.	Dispute Resolution.  The Company and Mr. Ervine agree to submit
to final and binding arbitration any and all disputes or disagreements
concerning the interpretation or application of this Agreement.  Any
such dispute or disagreement will be resolved by arbitration before a
single arbitrator in accordance with the Arbitration Rules of the
American Arbitration Association (the "AAA Rules").  Arbitration will
take place in Washington, DC, unless the parties mutually agree to a
different location.  The arbitrator shall be chosen in accordance with
the AAA Rules.  The arbitrator shall be bound to apply the provisions
of applicable substantive law and the Federal Rules of Evidence to any
dispute under this Agreement; provided, however, that punitive,
liquidated or indirect damages shall not be awarded by the arbitrator.
The arbitrator shall have the power to decide the claim upon motion of
the parties, without necessity of an oral arbitration evidentiary
hearing, if the parties agree in writing to waive such hearing or if
either party submits a motion requesting a hearing on documents only.
The arbitrator shall render a written reasoned opinion.  Mr. Ervine and
the Company agree that the decision of the arbitrator will be final and
binding on both parties.  Any court having jurisdiction may enter a
judgment upon the award rendered by the arbitrator.  If the arbitration
is decided in whole or in part in favor of Mr. Ervine, the Company will
reimburse Mr. Ervine for his reasonable costs and expenses of the
arbitration (including reasonable attorneys' fees).  Regardless of the
outcome of any arbitration, the Company will pay all fees and expenses
of the arbitrator and all of Company's costs of such arbitration.

11.	Successor Obligations and Assignment.  The rights and obligations
of the Company under this Agreement shall inure to the benefit of and
be binding upon the Company's successors and assigns.

12.	Amendment.  This Agreement may not be modified except by an
agreement in writing executed by both the Company and Mr. Ervine.

13.	Governing Law and Jurisdiction.  This Agreement shall be governed
by and construed in accordance with the laws of the Commonwealth of
Virginia, without giving effect to principles of conflicts of laws.

14.	Validity.  If any portion or provision of this Agreement is found
to be invalid or unenforceable, the other portions or provisions hereof
shall not be affected thereby.

                                     -7-

15.	Counterparts.  This Agreement may be executed in one or more
counterparts, each of which shall be deemed to be an original, but all
of which together shall constitute one and the same instrument.

16.	Construction of this Agreement and Certain Terms and Phrases.

       (a)	The section headings contained in this Agreement are
inserted for purposes of convenience of reference only and shall not
affect the meaning or interpretation hereof.

       (b)	Unless the context of this Agreement otherwise requires,
(i) words of any gender include each other gender; (ii) words using the
singular or plural number also include the plural or singular number,
respectively; (iii) the terms "hereof," "herein," "hereunder," "hereby"
and derivative or similar words refer to this entire Agreement; and
(iv) the term "Section" refers to the specified Section of this
Agreement.

       (c)	The word "including" is not exclusive; if exclusion is
intended, the word "comprising" is used instead.

       (d)	The word "or" shall be construed to mean "and/or" unless
the context clearly prohibits that construction.

       (e)	The Company and Mr. Ervine have participated jointly in the
negotiation and drafting of this Agreement. If an ambiguity or question
of intent or interpretation arises, this Agreement shall be construed
as if drafted jointly by the Company and Mr. Ervine and no presumption
or burden of proof shall arise favoring or disfavoring any party by
virtue of the authorship of any of the provisions of this Agreement.

17.	Effect of Agreement.  The terms and conditions of this Agreement
shall supersede any obligations and rights of the Company and its
subsidiaries, on the one hand, and Mr. Ervine, on the other hand,
respecting employment, mentoring, consulting and advisory services, and
compensation and benefits in respect of such services on or after April
28, 2008.  The execution of this Agreement shall constitute for all
purposes the termination, as of April 28, 2008, of the Ervine
Employment Agreement, except for the provisions of Sections 6(b), (c),
(d), (e), (f), (g) and (h) thereof, which shall survive the execution
of this Agreement and any reference in such surviving provisions to
"Term" shall be deemed to be for all purposes thereof the "Term" as
defined herein.

                                     -8-

       IN WITNESS WHEREOF, the parties have executed this Agreement as
of the date first above written.

                                             VSE Corporation

                                             By: /s/ C. S. Weber
                                                 ------------------------
                                                 C. S. Weber
                                                 Executive Vice President

                                                 /s/ Donald M. Ervine
                                                 ------------------------
                                                 Donald M. Ervine

                                     -9-exhibit_4-1.htm

    EXHIBIT
4.1

    SUBSCRIPTION
AGREEMENT

    

    

    THIS SUBSCRIPTION AGREEMENT
made as of this _____ day of _______ 2007 between NOBLE MEDICAL TECHNOLOGIES,
INC., a corporation organized under the laws of the State of Delaware
with offices 4430 Noble Avenue – Apartment 201, Sherman Oaks, CA 91403 (the
“Company”),
and the undersigned (the “Subscriber”
and together with each of the other subscribers in the Offering (defined below),
the “Subscribers”).

    

    WHEREAS, the Company desires
to issue up to $100,000 (100 Units) aggregate amount of units (a “Unit”
and collectively, the “Units”)
in a private placement (the “Offering”),
at a purchase price of $1,000 per Unit;

     

    WHEREAS, each Unit shall
consist of four thousand (4,000) shares of Common Stock, par value $.0001 per
share (the “Shares”); and

     

    WHEREAS, the Subscriber is
delivering simultaneously herewith a completed confidential investor
questionnaire (the “Questionnaire”),

     

    NOW, THEREFORE, for and in
consideration of the promises and the mutual covenants hereinafter set forth,
the parties hereto do hereby agree as follows:

     

    
      	
              I.  

            	
              SUBSCRIPTION FOR UNITS AND
      REPRESENTATIONS BY AND COVENANTS OF
SUBSCRIBER

            

    

     

    1.1. Subscription for Units.
Subject to the terms and conditions hereinafter set forth, the Subscriber
hereby subscribes for and agrees to purchase from the Company such aggregate
amount of Units as is set forth upon the signature page hereof; and the Company
agrees to sell such Units to the Subscriber for said purchase price subject to
the Company’s right to sell to the Subscriber such lesser number of Units as the
Company may, in its sole discretion, deem necessary or desirable. The purchase price is payable by
certified or bank check made payable to “Noble Medical Technologies, Inc.” and
delivered contemporaneously with the execution and delivery of this Subscription
Agreement to the Company’s address set forth above.

     

    1.2. Reliance on Exemptions. The
Subscriber acknowledges that this Offering has not been reviewed by the United
States Securities and Exchange Commission (“SEC”)
or any state agency because of the Company’s representations that this is
intended to be a nonpublic offering exempt from the registration requirements of
the Securities Act of 1933, as amended (the “1933
Act”) and state securities laws. The Subscriber understands that the
Company is relying in part upon the truth and accuracy of, and the Subscriber’s
compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Subscriber set forth herein in order to determine the
availability of such exemptions and the eligibility of the Subscriber to acquire
the Units.

     

    1.3. Investment Purpose. The
Subscriber represents that the Shares comprising the Units (the “Securities”)
are being purchased for his or her own account, for investment purposes only and
not for distribution or resale to others in contravention of the registration
requirements of the 1933 Act. The Subscriber agrees that it will
not

     

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    sell or
otherwise transfer the Securities unless they are registered under the 1933 Act
or unless an exemption from such registration is available.

     

    1.4. Accredited Investor. The
Subscriber represents and warrants that he or she is an “accredited investor” as
such term is defined in Rule 501 of Regulation D promulgated under the 1933 Act,
as indicated by its responses to the Questionnaire, and that it is able to bear
the economic risk of any investment in the Units. The Subscriber further
represents and warrants that the information furnished in the Questionnaire is
accurate and complete in all material respects.

     

    1.5. RISK OF INVESTMENT. THE SUBSCRIBER
RECOGNIZES THAT THE PURCHASE OF THE UNITS INVOLVES A HIGH DEGREE OF RISK
INCLUDING, WITHOUT

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    1.6. LIMITATION,
ANY AND ALL RISKS DISCUSSED IN THIS SUBSCRIPTION AGREEMENT.  AN
INVESTMENT IN THE COMPANY AND THE UNITS MAY RESULT IN THE LOSS OF A SUBSCRIBER’S
ENTIRE INVESTMENT.

     

    (a) Risk of Loss of
Investment.  An investment in the Company and the Units offered
hereby involve a high degree of risk.  An investment in the Units is
suitable only for investors who can bear a loss of their entire
investment.

     

    (b) Value of Shares is
Speculative.  The terms of this offering have been determined
arbitrarily by the Company.  There is no relationship between such
terms and the Company’s assets, earnings, book value and/or any other objective
criteria of value.

     

    (c) Dependence on Net Proceeds;
No Minimum Offering.  The Company is wholly dependent upon the
net proceeds of this Offering to fund its operations, as more specifically
described elsewhere in this Subscription Agreement. There is no commitment by
any person to purchase Units and there is no assurance that any number of Units
will be sold.  Additionally, there is no minimum amount of funds that
are required to be raised in order for the Company to accept subscriptions
received from investors and the Company’s may terminate this Offering prior to
the expiration of the Offering Period. There is no assurance that the Company
will sell a sufficient number of Units in this Offering on a timely basis or
that the net proceeds after payment of debts and other obligations will be
adequate for the Company’s needs.

     

    (d) Need for Additional Capital;
Additional Private Placement.  The net proceeds raised by the
Company from this Offering will be used immediately to fund the Company’s
current operations. The Company will therefore require significant additional
financing shortly after this Offering, regardless of the net proceeds received,
in order to satisfy its cash requirements. Upon completion of this offering, the
Company intends to affect a registration on Form SB-2, become a publicly traded
entity and seek to raise additional funds in private placement transactions.
However, there is no assurance that it will be able to do so in a timely manner
or on terms that will enable it to enter its proposed business on a reasonable
basis.

     

    (e) Restrictions on
Resale.  The Units and the Shares, are “restricted” securities
and may not be resold or otherwise transferred except pursuant to an effective
registration statement or an exemption under the 1933 Act and applicable state
or “blue sky” laws.

     

    (f) No Operating History;
History of Losses or Nominal Income; Development Stage
Entity.  The Company not commenced operations.  To
date and since inception, the Company has not generated any
revenues.  The Company expects to incur substantial losses for the
foreseeable future and has no operating history on which the Company can
evaluate its potential for future success.  The Company is a
developmental stage entity.  To evaluate the Company, investors should
evaluate the Company in light of the expenses, delays, uncertainties, and
complications typically encountered by early-stage development businesses, many
of which are beyond the Company’s control.  Early-stage development
businesses commonly face risks such as the following:

     

    
      	
              ·  

            	
              lack of sufficient
      capital;

            

    

     

    
      	
              ·  

            	
              unanticipated problems, delays,
      and expenses relating to product development and
      implementation;

            

    

    
      	
              ·  

            	
              lack of intellectual
      property;

            

    

    
      	
              ·  

            	
              licensing and marketing
      difficulties;

            

    

    
      	
              ·  

            	
              competition;

            

    

    
      	
              ·  

            	
              technological changes;
      and

            

    

    
      	
              ·  

            	
              uncertain market acceptance of
      products and services.

            

    

    

    (g) Dependence upon the
Company’s Sole Officer and Director. The
Company is wholly dependent upon Richard Krutosik, currently the sole officer
and director of the Company, for the operations and success of the
Company.  The loss of his services would have a material adverse
effect on the Company’s business,

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    (h) financial
condition and results of operations.  The Company does not have an
employment agreement with Peter Destler who is expected to devote only a portion
of his working time to the affairs of the Company.

     

    (i) Capital Structure of the
Company.  The following sets forth the capital structure of the
Company prior to the sale of any Securities in this Offering.

     

    (i)           The
Company has twenty one million (21,000,000) authorized shares of capital stock
consisting of (A) twenty million (20,000,000) shares of Common Stock and one
million (1,000,000) shares of blank check preferred stock.

     

    (ii)           The
Company has 4,000,000 shares of Common Stock issued and outstanding as
follows:

     

    (A) Richard Krutosik – 3,920,000;
and

    

    (B) Frank J. Hariton – 80,000
Shares.

    

    Mr.
Richard Krutosik may reallocate a portion of his shares in the
future.

    

    (iii)           The
Company has no other securities currently issued and outstanding and there are
no warrants, options or other securities outstanding that are convertible into
or exercisable for any securities of the Company.

    

    1.6           Summary of Proposed
Business.      The Company intends to
develop, manufacture and market its “multi-lead retractable console” for
electrocardiogram (“EKG”) equipment which it believes will be accepted by the
market as it will save medical technician’s time in attaching the multiple leads
necessary to a patient in situations where time can be critical to the medical
outcome.  The Company will secure office space, hire necessary
personnel, further develop the design for its product, consider and possibly
apply for patent protection, either manufacture or arrange for the manufacture
of its product, and commence its marketing efforts. There is no assurance that
the Company will be successful in these endeavors or that if accomplishes all of
these steps it will be able to operate profitably.  No assurance is
given that the Company will be granted a patent if it chooses to apply for one,
that any such patent will offer the Company meaningful against infringement or
that such patent would not be found to infringe upon patents granted by others.
Based on management’s personal experience, the Company believes that its product
is a legitimate business opportunity for the Company and its
shareholders.

    

    1.7 Information.  The
Subscriber acknowledges receipt and full and careful review and understanding of
this Subscription Agreement with any exhibits thereto (the “Offering Document”) and hereby
represents that: (i) it has been furnished by the Company during the course of
this transaction with all information regarding the Company which it has
requested; and (ii) that it has been afforded the opportunity to ask questions
of and receive answers from duly authorized officers of the Company concerning
the terms and conditions of the Offering, and any additional information which
it has requested.

     

    1.8 No Representations or
Warranties.  The Subscriber hereby represents that, except as
expressly set forth in the Offering Document, no representations or warranties
have been made to the Subscriber by the Company or any agent, employee or
affiliate of the Company and in entering into this transaction the Subscriber is
not relying on any information other than that contained in the Offering
Documents and the results of independent investigation by the
Subscriber.

     

    1.9 Tax Consequences. The
Subscriber acknowledges that this Offering of the Units may involve tax
consequences and that the contents of the Offering Documents do not contain tax
advice or information. The Subscriber acknowledges that it must retain its own
professional advisors to evaluate the tax and other consequences of an
investment in the Units.

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    1.10 Transfer or Resale. The
Subscriber understands that: (a) none of the Securities have been and are not
being registered under the 1933 Act or any state securities laws; (b) the
Securities may not be offered for sale, sold, assigned, pledged, transferred or
otherwise disposed of (each a “Disposition”)
unless, prior to effecting any such Disposition (other than any transfer not
involving a change in beneficial ownership) (i) there is in effect a
registration statement under the 1933 Act covering the Disposition and the
Disposition is made in accordance with such registration statement, or (ii) the
Subscriber gives written notice to the Company of such Subscriber’s intention to
effect a Disposition and such notice shall describe the manner and circumstances
of the proposed Disposition, and shall be accompanied by either (A) a written
opinion of a legal counsel that a Disposition of the Securities may be made
pursuant to an exemption from such registration, or (B) any other evidence
reasonably satisfactory to counsel to the Company; and (C) the Company is under
no obligation to register the Securities under the 1933 Act or any state
securities laws or to comply with the terms and conditions of any registration
exemption thereunder.

     

    1.11 Legends. The Subscriber
understands that the certificates or other instruments representing the
Securities, until such time as they have been registered under the 1933 Act as
contemplated by the Registration Rights Agreement, shall bear a restrictive
legend in substantially the following form (and a stop-transfer order may be
placed against transfer of such certificates or other instruments):

     

    THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE
SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE
ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, OR (B)
AN OPINION OF COUNSEL, IN A REASONABLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT
REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS.

     

    The
legend set forth above shall be removed and the Company shall issue a
certificate or other instrument without such legend to the holder of the
Securities upon which it is stamped, if (a) there is in effect a registration
statement under the 1933 Act covering the Disposition and the Disposition is
made in accordance with such registration statement or (b) if the Disposition of
the Securities is completed in satisfaction of the requirements of Rule 144 of
the 1933 Act.

     

    1.12 Validity;
Enforcement.  If the Subscriber is a corporation, partnership,
trust or other entity, the Subscriber represents and warrants that: (a) it is
authorized and otherwise duly qualified to purchase and hold the Units; and (b)
that this Subscription Agreement has been duly and validly authorized, executed
and delivered and constitutes the legal, binding and enforceable obligation of
the undersigned.

     

    1.13 Residency. The Subscriber
represents that its principal address is furnished at the end of this
Subscription Agreement.

     

    1.14 Foreign Subscriber. If the
Subscriber is not a United States person, such Subscriber hereby represents that
it has satisfied itself as to the full observance of the laws of its
jurisdiction in connection with any invitation to subscribe for the Units or any
use of this Subscription Agreement, including: (a) the legal requirements within
its jurisdiction for the purchase of the Units; (b) any foreign exchange
restrictions applicable to such purchase; (c) any governmental or other consents
that may need to be obtained; and (d) the income tax and other tax consequences,
if any, that may be relevant to the purchase, holding, redemption, sale or
transfer of the securities comprising the Units. Such Subscriber’s subscription
and payment for, and his or her continued beneficial ownership of the Units,
will not violate any applicable securities or other laws of the Subscriber’s
jurisdiction.

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    1.15 NASD Member. The Subscriber
acknowledges that if it is a Registered Representative of an NASD member firm,
the Subscriber must give such firm notice required by the NASD’s Rules of Fair
Practice, receipt of which must be acknowledged by such firm on the signature
page hereof.

     

    1.16 Escrow Agent; Escrow
Agreement. Pursuant to the terms of an escrow agreement (the “Escrow
Agreement”) by and between the Company and Frank J. Hariton, Esq., as
escrow agent (the “Escrow
Agent”) for the Offering, all proceeds from the sale of the Units shall
be sent directly to and held in escrow by the Escrow Agent pending each Closing
(as defined below).

     

    1.17 Confidential
Information.  The subscriber acknowledges that the information
contained in this Subscription Agreement and the related schedules and Exhibits,
as well as any other information relating to the Company that has been provided
to the Subscriber in connection with this Offering is the confidential and
proprietary information of the Company.  The Subscriber agrees that he
shall not disclose any of said information to any other person, except for his
financial and legal advisors, who require such information to advise the
Subscriber with respect to his contemplated investment, and in the event that
the Subscriber does not invest in this Offering, he shall return all materials
provided to him by the Company, including any copies thereof, to the
Company.

     

    II. REPRESENTATIONS BY THE
COMPANY

     

    The
Company represents and warrants to the Subscriber, except as set forth in the
disclosure schedules attached hereto:

     

    2.1           Organization and Qualification.
The Company and its “Subsidiaries”
(which for purposes of this Subscription Agreement means any entity in which the
Company, directly or indirectly, owns capital stock and holds a majority or
similar interest) are duly organized and validly existing in good standing under
the laws of the jurisdiction in which they were organized, and have the
requisite power and authorization to own their properties and to carry on their
business as now being conducted. Each of the Company and its Subsidiaries is
duly qualified as a foreign corporation to do business and is in good standing
in every jurisdiction in which its ownership of property or the nature of the
business conducted by it makes such qualification necessary, except to the
extent that the failure to be so qualified or be in good standing would not have
a Material Adverse Effect. As used in this Subscription Agreement, “Material
Adverse Effect” means any material adverse effect on the business,
properties, assets, operations, results of operations or financial condition of
the Company and its Subsidiaries, if any, taken as a whole, or on the
transactions contemplated hereby, or by the other Offering Documents or the
agreements and instruments to be entered into in connection herewith or
therewith, or on the authority or ability of the Company to perform its
obligations under the Offering Documents.

     

    2.2           Authorization; Enforcement;
Validity. The Company has the requisite corporate power and authority to
enter into and perform its obligations under this Subscription Agreement and the
Escrow Agreement and to perform its obligations under the Offering Document, and
to issue the Securities in accordance with the terms of the Offering Document.
The execution and delivery of the Offering Document by the Company and the
consummation by the Company of the transactions contemplated by the Offering
Documents, including without limitation the issuance of the Securities, have
been duly authorized by the Company’s board of directors and no further consent
or authorization is required by the Company, its board of directors or its
stockholders. The Offering Documents have been duly executed and delivered by
the Company, and constitute valid and binding obligations of the Company
enforceable against the Company in accordance with their terms, except as such
enforceability may be limited by general principles of equity or applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws
relating to, or affecting generally, the enforcement of creditors’ rights and
remedies.

     

    2.3           Capitalization. Prior to the
Initial Closing, the authorized, issued and outstanding securities of the
Company (including, but not limited to, all and/or other securities convertible
into equity securities of the Company and all options and warrants, all of which
are listed in Section
1.1(i) of this Subscription Agreement.  All of the issued and
outstanding securities of the Company have been and are, or upon issuance will
be duly authorized, validly issued, fully paid and non-assessable. Except as
disclosed in Offering Document, (i) no shares of the Company's capital stock are
subject to preemptive rights under Delware law or any other similar rights or
any liens

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    or
encumbrances suffered or permitted by the Company; (ii) there are no outstanding
debt securities issued by the Company; (iii) there are no outstanding options,
warrants, scrip, rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities or rights convertible into or exchangeable
for, any shares of capital stock of the Company or any of its Subsidiaries, or
contracts, commitments, understandings or arrangements by which the Company or
any of its Subsidiaries is or may become bound to issue additional shares of
capital stock of the Company or any of its Subsidiaries or options, warrants,
scrip, rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into or exchangeable for, any
shares of capital stock of the Company or any of its Subsidiaries; (iv) there
are no agreements or arrangements under which the Company or any of its
Subsidiaries is obligated to register the sale of any of their securities under
the 1933 Act; (v) there are no outstanding securities of the Company or any of
its Subsidiaries which contain any redemption or similar provisions, and there
are no contracts, commitments, understandings or arrangements by which the
Company or any of its Subsidiaries is or may become bound to redeem a security
of the Company or any of its Subsidiaries; (vi) there are no securities or
instruments containing anti-dilution or similar provisions that will be
triggered by the issuance of the Securities as described in the Offering
Documents; and (vii) the Company does not have any stock appreciation rights or
“phantom stock” plans or agreements or any similar plan or agreement. All prior
sales of securities of the Company were either registered under the 1933 Act and
applicable state securities laws or exempt from such registration, and no
security holder has any rescission rights with respect thereto.

     

    2.4           Issuance of Securities;
Reservation. The issuance, sale and delivery of the Securities have been
duly authorized by all requisite corporate action by the Company and, upon
issuance in accordance with the Offering Documents, shall be (a) duly
authorized, validly issued, fully paid and non-assessable, (b) free from all
taxes, liens and charges with respect to the issue thereof except that may be
created by the Subscriber, and (c) entitled to the rights and preferences set
forth in the Securities. Assuming (i) the accuracy of the information provided
by the respective Subscribers in the Subscription Agreement and Questionnaire,
and (ii) that all of the offerees and Subscribers are “accredited investors” as
such term is defined in Rule 501 of Regulation D, the offer and sale of the
Units pursuant to the terms of this Subscription Agreement are and will be
exempt from the registration requirements of the 1933 Act and the rules and
regulations promulgated thereunder. The Company is not disqualified from the
exemption under Regulation D by virtue of the disqualification contained in Rule
507 thereof or otherwise.

     

    2.5           No Conflicts. Except as set
forth in the Offering Documents, the execution, delivery and performance of the
Offering Documents by the Company, the consummation by the Company of the
transactions contemplated by the Offering Documents, and the issuance of the
Securities and performance by the Company of its obligations under the Offering
Documents, will not (a) result in a violation of the Company’s Certificate of
Incorporation, any other certificate of designations, preferences and rights of
any outstanding series of preferred stock of the Company, or the Company’s
By-Laws, (b) conflict with, or constitute a default or an event which with
notice or lapse of time or both would become a default under, or give to others
any rights of termination, amendment, acceleration or cancellation of, any
material agreement, note and/or other indebtedness, lease, license or
instrument, or (c) result in a violation of any law, rule, regulation, order,
judgment or decree (including federal and state securities laws and regulations
and the rules and regulations of the NASD) applicable to the Company or any of
its Subsidiaries or by which any property or asset of the Company or any of its
Subsidiaries is bound or affected.

     

    2.6 Consents. The Company is not
required to obtain any consent, authorization or order of, or make any filing or
registration with, any court or governmental agency or any regulatory or
self-regulatory agency in order for it to execute, deliver or perform any of its
obligations under or contemplated by the Offering Documents. Except as otherwise
provided in the Offering Documents, all consents, authorizations, orders,
filings and registrations which the Company is required to obtain pursuant to
the preceding sentence have been obtained or effected on or prior to the date
hereof. The Company and its Subsidiaries are unaware of any facts or
circumstances which might prevent the Company from obtaining or effecting any of
the foregoing.

     

    2.7 No General Solicitation. None
of the Company, its Subsidiaries, any of their affiliates, and any person acting
on their behalf, has engaged in any form of general solicitation or

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    2.8 general
advertising (within the meaning of Regulation D under the 1933 Act) in
connection with the offer or sale of the Securities.

     

    2.9 No Integrated Offering. None
of the Company, its Subsidiaries, any of their affiliates, and any person acting
on their behalf has, directly or indirectly, made any offers or sales of any
security or solicited any offers to buy any security, under circumstances that
would require registration of any of the Securities under the 1933 Act by
causing this Offering of the Securities to be integrated with prior offerings by
the Company for purposes of the 1933 Act or any applicable stockholder approval
provisions, including without limitation, under the rules and regulations of any
exchange or automated quotation system on which any of the securities of the
Company are listed or designated, or otherwise. None of the Company, its
Subsidiaries, their affiliates and any person acting on their behalf will take
any action or steps referred to in the preceding sentence that would require
registration of any of the Securities under the 1933 Act by causing the Offering
of the Securities to be integrated with other offerings, or
otherwise.

     

    2.10 Foreign Corrupt Practices.
Neither the Company, nor any of its Subsidiaries, nor any director,
officer, agent, employee or other person acting on behalf of the Company or any
of its Subsidiaries has, in the course of its actions for, or on behalf of, the
Company, (a) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expenses relating to political activity; made
any direct or indirect unlawful payment to any foreign or domestic government
official or employee from corporate funds, (b) violated or is in violation of
any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or
(c) made any unlawful bribe, rebate, payoff, influence payment, kickback or
other unlawful payment to any foreign or domestic government official or
employee.

     

    2.11  Absence of Litigation.
Except as set forth in the Offering Document, there is no action, suit,
proceeding, inquiry or investigation before or by the NASD, any court, public
board, government agency, self-regulatory organization or body, or arbitrator
pending or, to the knowledge of the Company, threatened against the Company, the
Common Stock or any of the Company’s Subsidiaries or any of the Company’s or the
Company’s Subsidiaries’ officers or directors in their capacities as
such.

     

    2.12 Tax Status. Except as set
forth in the Offering Document, the Company and each of its Subsidiaries has
made or filed all federal and state income and all other tax returns, reports
and declarations required by any jurisdiction to which it is subject, except
when the failure to do so would not have a Material Adverse Effect, and has paid
all taxes and other governmental assessments and charges that are material in
amount, shown or determined to be due on such returns, reports and declarations
or to the Company’s knowledge otherwise due and payable, except those being
contested in good faith and has set aside on its books reserves in accordance
with GAAP reasonably adequate for the payment of all taxes for periods
subsequent to the periods to which such returns, reports or declarations apply.
There are no unpaid taxes in any material amount claimed to be due by the taxing
authority of any jurisdiction, and the officers of the Company know of no basis
for any such claim.

     

    2.13 Securities Law Compliance. The
offer, offer for sale, and sale of the Units has not been registered with the
SEC. The Units are to be offered, offered for sale and sold in reliance upon the
exemptions from the registration requirements of Section 5 of the 1933 Act. The
Company will conduct the Offering in compliance with the requirements of
Regulation D under the 1933 Act, and the Company will file all appropriate
notices of offering with the SEC.

     

    2.14 Title. Except as set forth in
or contemplated by the Offering Document, the Company has good and marketable
title to all material properties and tangible assets owned by it, free and clear
of all liens, charges, encumbrances or restrictions, except as such as are not
significant or important in relation to the Company’s business; all of the
material leases and subleases under which the Company

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

    2.15 is the
lessor or sublessor of properties or assets or under which the Company holds
properties or assets as lessee or sublessee are in full force and effect, and
the Company is not in default in any material respect with respect to any of the
terms or provisions of any of such leases or subleases, and to the Company’s
knowledge no material claim has been asserted by anyone adverse to rights of the
Company as lessor, sublessor, lessee or sublessee under any of the leases or
subleases mentioned above, or affecting or questioning the right of the Company
to continued possession of the leased or subleased premises or assets under any
such lease or sublease. The Company owns, leases or licenses all such properties
as are necessary to its operations as described in the Offering
Documents.

     

    2.16 Intellectual Property Rights.
The Company and its Subsidiaries own or possess adequate rights or licenses to
use all trademarks, trade names, service marks, service mark registrations,
service names, patents, patent rights, copyrights, inventions, licenses,
approvals, governmental authorizations, trade secrets and rights necessary to
conduct their respective businesses as now conducted, the lack of which could
reasonably be expected to have a Material Adverse Effect. Except as set forth in
the Offering Documents, to the Company’s knowledge, none of the Company's
trademarks, trade names, service marks, service mark registrations, service
names, patents, patent rights, copyrights, inventions, licenses, approvals,
government authorizations, trade secrets or other intellectual property rights
have expired or terminated, or are expected to expire or terminate within two
(2) years from the date of this Subscription Agreement, except where such
expiration or termination would not have either individually or in the aggregate
a Material Adverse Effect. The Company and its Subsidiaries do not have any
knowledge of any infringement by the Company or its Subsidiaries of trademarks,
trade name rights, patents, patent rights, copyrights, inventions, licenses,
service names, service marks, service mark registrations, trade secrets or other
similar rights of others, or of any such development of similar or identical
trade secrets or technical information by others and, except as set forth in the
Offering Document, no claim, action or proceeding has been made or brought
against, or to the Company's knowledge, has been threatened against, the Company
or its Subsidiaries regarding trademarks, trade name rights, patents, patent
rights, inventions, copyrights, licenses, service names, service marks, service
mark registrations, trade secrets or other infringement, except where such
infringement, claim, action or proceeding would not reasonably be expected to
have either individually or in the aggregate a Material Adverse Effect. Except
as set forth in the Offering Document, the Company and its Subsidiaries are
unaware of any facts or circumstances which might give rise to any of the
foregoing. The Company and its Subsidiaries have taken reasonable security
measures to protect the secrecy, confidentiality and value of all of their
intellectual properties except where the failure to do so would not have either
individually or in the aggregate a Material Adverse Effect.

     

    2.17 Registration Rights. Except as
set forth in the Offering Document, no person has any right to cause the Company
to effect the registration under the 1933 Act of any securities of the
Company.

     

    2.18 Brokers. Neither the Company
nor any of its officers, directors, employees or stockholders has employed any
broker or finder in connection with the transactions contemplated
herein.

     

    2.19 Disclosure. None of the
representations and warranties of the Company appearing in this Subscription
Agreement or any information appearing in any Exhibit or Schedule hereto other
than material which says it is a “belief” or “expectation” of the Company or
similarly qualified, which statements the Company believes to the best of its
knowledge as of the date hereof and at each Closing Date to be true and accurate
in all material respects and not misleading), when considered together as a
whole, contains, or on any Closing Date will contain, any untrue statement of a
material fact or omits, or on any Closing Date will omit, to state any material
fact required to be stated herein or therein in order for the statements herein
or therein, in light of the circumstances under which they were made, not to be
misleading.

     

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

    2.20 TERMS OF SUBSCRIPTION

     

    3.1           Closing and Termination of
Offering.  Provided that the required conditions to closing set
forth in Article
V and Article
VI hereof have been satisfied or waived, a closing (the “Initial
Closing”) shall take place at the offices of the Company as set forth
herein or at such place as may otherwise be agreed to by the Company within 30
days of the receipt of the first cleared subscriber’s funds.  The
Company may consummate subsequent closings of the Offering, upon mutual
agreement only, each of which shall be subject to satisfaction or waiver of the
conditions to closing set forth in Article
V and Article
VI hereof, and each of which shall be deemed a “Closing”
hereunder. The date of the last closing of the Offering is hereinafter referred
to as the “Final
Closing” and the date of any Closing hereunder is hereinafter referred to
as a “Closing
Date.” The offering period for the Offering shall commence on the day the
Offering Document is first delivered to prospective Subscribers by the Company
for delivery in connection with the offering for sale of the Units and shall
continue until the earlier to occur of: (i) the sale of the all of the Units
being offered pursuant to this Offering; and (ii) 5:00 p.m. (New York time),
Novmber 30, 2007; provided, however, that (A) if
all of the Units have not been sold on or prior to November 30, 2007, this
Offering may be extended for an additional ninety (90) days by the Company in
its sole discretion and (B) this Offering may be terminated prior to November
30, 2007, upon the sole action of the Company. The day that the Offering Period
terminates is hereinafter referred to as the “Termination
Date.”

     

    3.2 Certificates. The Subscriber
hereby authorizes and directs the Company, upon each closing of the Offering, to
(i) deliver the certificates representing the Shares (the “Stock
Certificates”) to be issued to such Subscriber pursuant to this
Subscription Agreement to the Subscriber’s address indicated in the
Questionnaire, by thirty (30) days after the applicable Closing
Date.

     

    III. COVENANTS

     

    

    3.3 Form D and Blue Sky. The
Company shall file a Form D with respect to the Units as required under
Regulation D under the 1933 Act and, upon written request, provide a copy
thereof to the Subscriber promptly after such filing. The Company shall, on or
before the Closing, take such action as the Company shall reasonably determine
is necessary in order to obtain an exemption for or to qualify the Units for
sale to the Subscriber pursuant to this Subscription Agreement under applicable
securities or “Blue Sky” laws of the states of the United States, and shall
provide evidence of any such action so taken to the Subscriber on or prior to
the Closing. The Company shall make all filings and reports relating to the
offer and sale of the Securities required under applicable securities or “Blue
Sky” laws of the states of the United States following the Closing.

     

    3.4 Use of Proceeds. The Company
shall only use the net proceeds from the sale of the Units for the following
purposes:

     

    (a)           To
pay the expenses of the Offering, including, but not limited to legal and
accounting fees;

     

    (b)           To
fund the costs of a Securities Act Registration Statement; and

     

    (c)           Working
capital requirements.

     

    

    IV. CONDITIONS TO CLOSING IN FAVOR OF THE
COMPANY

    

    The
obligation of the Company hereunder to issue and sell Units to the Subscriber at
the Closing is subject to the satisfaction, at or before the Closing, of each of
the following conditions, provided that these conditions are for the Company’s
sole benefit and may be waived by the Company at any time in its sole discretion
by providing the Subscriber with prior written notice thereof:

     

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

    5.1           Offering Documents. The
Subscriber shall have executed a Questionnaire, a Subscription Agreement and
delivered the same to the Company.

     

    5.2           Purchase Price. The Subscriber
shall have paid the purchase price for the Units being purchased by the
Subscriber at the Closing in the manner set forth in Section
1.1.

     

    5.3           Representations and
Warranties. The representations and warranties of the Subscriber shall be
true and correct in all material respects as of the date when made and as of the
Closing as though made at that time, and the Subscriber shall have performed,
satisfied and complied in all material respects with the covenants, agreements
and conditions required by this Subscription Agreement to be performed,
satisfied or complied with by the Subscriber at or prior to the
Closing.

     

    5.4           Other Matters. All opinions,
certificates and documents and all proceedings related to this Offering shall be
in form and content reasonably satisfactory to the Company and its legal
counsel.

     

    VI. CONDITIONS TO CLOSING IN FAVOR OF THE
SUBSCRIBER

     

    The
obligation of the Subscriber hereunder to purchase the Units is subject to the
satisfaction, at or before the Closing, of each of the following conditions,
provided that these conditions are for the Subscriber’s sole benefit and may be
waived by the Subscriber at any time in its sole discretion by providing the
Company with prior written notice thereof:

     

    6.1 Offering Documents. The
Company shall have executed and delivered to the Subscriber each of the Offering
Documents to which its signature is required.

     

    6.2 Representations and
Warranties. The representations and warranties of the Company shall be
true and correct as of the date when made and as of the Closing as though made
at that time (except for representations and warranties that reference a
specific date which shall have been true and correct in all material respects as
of such date), and the Company shall have performed, satisfied and complied in
all respects with the covenants, agreements and conditions required by the
Offering Documents to be performed, satisfied or complied with by the Company at
or prior to the Closing.

     

    VII. RIGHTS OF TERMINATION

     

    

    6.3 Termination by Subscriber or Company.
This Subscription Agreement may be terminated at any time prior to the
Closing: (a) by mutual written consent of the parties hereto; or (b) by the
Company or the Subscriber upon written notice to the other party if any court or
governmental authority of competent jurisdiction shall have issued a final,
non-appealable order restraining, enjoining or otherwise prohibiting the
consummation of the transactions contemplated by this Subscription Agreement.
Termination of this Subscription Agreement under this Section
7.1 shall
result in this Subscription Agreement becoming void and of no further force and
effect, except that a termination shall not release, or be construed as so
releasing, any party hereto from any liability or damage to the other party
hereto arising out of the breaching party’s willful and material breach of the
warranties and representations made by it, or willful and material failure in
performance of any of its covenants, agreements, duties or obligations provided
hereunder, and the obligations under Section
8.8 shall survive such termination.

     

    

     

    VIII.           MISCELLANEOUS

     

    

    8.1 Notice. Any notices, consents,
waivers or other communications required or permitted to be given under the
terms of this Subscription Agreement must be in writing and will be deemed to
have been delivered: (a)

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

    8.2 upon
receipt, when delivered personally, (b) upon receipt, when sent by facsimile
(provided confirmation of transmission is mechanically or electronically
generated and kept on file by the sending party), or (c) one (1) business day
after deposit with an overnight courier service, in each case properly addressed
to the party to receive the same. The addresses and facsimile numbers for such
communications shall be:

    

    If to the
Company at the address set forth in the first paragraph of this agreement,
Attn.: President.

    If to the
Subscriber, to its address and facsimile number set forth at the end of this
Subscription Agreement, or to such other address and/or facsimile number and/or
to the attention of such other person as specified by written notice given to
the Company five (5) days prior to the effectiveness of such
change.

     

    Written
confirmation of receipt (a) given by the recipient of such notice, consent,
waiver or other communication, (b) mechanically or electronically generated by
the sender’s facsimile machine containing the time, date, recipient facsimile
number and an image of the first page of such transmission, or (c) provided by
an overnight courier service shall be rebuttable evidence of personal service,
receipt by facsimile or receipt from an overnight courier service in accordance
with clauses (a), (b) or (c) above, respectively.

     

    8.3 Entire Agreement; Amendment.
This Subscription Agreement supersedes all other prior oral or written
agreements between the Subscriber, the Company, their affiliates and persons
acting on their behalf with respect to the matters discussed herein, and this
Subscription Agreement and the instruments referenced herein contain the entire
understanding of the parties with respect to the matters covered herein and
therein and, except as specifically set forth herein or therein, neither the
Company nor the Subscriber makes any representation, warranty, covenant or
undertaking with respect to such matters. No provision of this Subscription
Agreement may be amended or waived other than by an instrument in writing signed
by the Company and each Noteholder.

     

    8.4 Severability. If any provision
of this Subscription Agreement shall be invalid or unenforceable in any
jurisdiction, such invalidity or unenforceability shall not affect the validity
or enforceability of the remainder of this Subscription Agreement in that
jurisdiction or the validity or enforceability of any provision of this
Subscription Agreement in any other jurisdiction.

     

    8.5 Governing Law; Jurisdiction.
This Agreement shall be governed by and construed solely in accordance
with the internal laws of the State of New York with respect to contracts
executed, delivered and to be fully performed therein, without regard to the
conflicts of laws principles thereof. The parties hereto hereby expressly and
irrevocably agree that any suit or proceeding arising under this Agreement or
the consummation of the transactions contemplated hereby, shall be brought
solely in a federal or state court located in the City, County and State of New
York. By its execution hereof, Company and Subscriber hereby expressly and
irrevocably submits to the in personam jurisdiction
of the federal and state courts located in the City, County and State of New
York and agree that any process in any such action may be served upon him or her
personally, or by certified mail or registered mail upon such party or such
agent, return receipt requested, with the same full force and effect as if
personally served upon such party in New York, New York. The parties hereto each
waive any claim that any such jurisdiction is not a convenient forum for any
such suit or proceeding and any defense or lack of in personam
jurisdiction with respect thereto. In the event of any such action or
proceeding, the party prevailing therein shall be entitled to payment from the
other party hereto of its reasonable counsel fees and
disbursements.

     

    8.6 Headings. The headings of this
Subscription Agreement are for convenience of reference and shall not form part
of, or affect the interpretation of, this Subscription Agreement.

     

    8.7 Successors And Assigns. This
Subscription Agreement shall be binding upon and inure to the benefit of the
parties and their respective successors and assigns, including any purchasers of
the Units. The Company shall not assign this Subscription Agreement or any
rights or obligations hereunder. Subscriber may assign some or all of its rights
hereunder without the consent of the Company, provided, however, that any
such assignment shall not release the Subscriber from its

     

    
      
         

      

      
        12

        
          

        

      

      
         

      

    

    8.8 obligations
hereunder unless such obligations are assumed by such assignee and the Company
has consented to such assignment and assumption, which consent shall not be
unreasonably withheld.

     

    8.9 No Third Party Beneficiaries.
This Subscription Agreement is intended for the benefit of the parties
hereto and their respective permitted successors and assigns, and is not for the
benefit of, nor may any provision hereof be enforced by, any other
person.

     

    8.10 Survival. The representations
and warranties of the Company and the Subscriber contained in Article
I and Article
II and the agreements set forth this Article
VIII shall survive the Closing for a period of twelve (12)
months.

     

    8.11 Further Assurances. Each party
shall do and perform, or cause to be done and performed, all such further acts
and things, and shall execute and deliver all such other agreements,
certificates, instruments and documents, as the other party may reasonably
request in order to carry out the intent and accomplish the purposes of this
Subscription Agreement and the consummation of the transactions contemplated
hereby.

     

    8.12 No Strict Construction. The
language used in this Subscription Agreement will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules of strict
construction will be applied against any party.

     

    8.13 Legal Representation. The
Subscriber acknowledges that: (a) it has read this Subscription Agreement and
the exhibits hereto; (b) it understands that the Company has been represented in
the preparation, negotiation, and execution of this Subscription Agreement by
Frank Hariton, Esq., counsel to the Company; (c) it has either been represented
in the preparation, negotiation, and execution of this Subscription Agreement by
legal counsel of its own choice, or has chosen to forego such representation by
legal counsel after being advised to seek such legal representation; and (d) it
understands the terms and consequences of this Subscription Agreement and is
fully aware of its legal and binding effect.

     

    8.14 Confidentiality. The
Subscriber agrees that it shall keep confidential and not divulge, furnish or
make accessible to anyone, the confidential information concerning or relating
to the business or financial affairs of the Company contained in the Offering
Documents to which it has become privy by reason of this Subscription
Agreement.

     

    8.15 Counterparts. This
Subscription Agreement may be executed in two or more identical counterparts,
all of which shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the
other party; provided that a facsimile signature shall be considered due
execution and shall be binding upon the signatory thereto with the same force
and effect as if the signature were an original, not a facsimile
signature.

     

    

     

    

     

    

     

    

     

    

     

    

     

    

     

    Remainder
of Page Intentionally Left Blank

     

    
      
         

      

      
        13

        
          

        

      

      
         

      

    

    

    IN WITNESS WHEREOF, the
parties have executed this Subscription Agreement as of the date first written
above.

    

    
      	
              SUBSCRIBER
      **

            	 
      	
              CO-SUBSCRIBER
      **

            
	 
      	 
      	 
      
	
              Signature
      of Subscriber

            	 
      	
              Signature
      of Co-Subscriber

            
	 
      	 
      	 
      
	
              Name
      of Subscriber [please print]

            	 
      	
              Name
      of Co-Subscriber [please print]

            
	 
      	 
      	 
      
	
              Address
      of Subscriber

            	 
      	
              Address
      of Co-Subscriber

            
	 
      	 
      	 
      
	
              Social
      Security or Taxpayer

              Identification
      Number of Subscriber

            	 
      	
              Social
      Security or Taxpayer Identification

              Number
      of Co-Subscriber

            
	
               

              Name
      of Holder(s) as it should appear on the security certificates* [please
      print]

            	 
      

    

    

    * Please
provide the exact names that you wish to see on the certificates

    

    (1)           For
individuals, print full name of subscriber.

    (2)           For
joint, print full name of subscriber and all co-subscribers.

    (3)           For
corporations, partnerships, LLC, print full name of entity, including “&,”
“Co.,” “Inc.,” “etc,” “LLC,” “LP,” etc.

    (4)           For
Trusts, print trust name (please contact your trustee for the exact name that
should appear on the certificates.)

    

    

    Dollar
Amount of Units Subscribed For:
$                                                                                                

    

    Dollar
Amount of Units

    Subscription
Accepted:
$                                                                

    

    SUBSCRIPTION
ACCEPTED BY THE COMPANY

    

    NOBLE
MEDICAL TECHNOLOGIES, INC.

    

    

    By:                                                                

    Richard
Krutosik , President & CEO

    

    **If
Subscriber is a Registered Representative with an NASD member firm or an
affiliated person of an NASD member firm, have the acknowledgment to the right
signed by the appropriate party:

    

    The
undersigned NASD Member firm acknowledges receipt of the notice required by Rule
3040 of the NASD Conduct Rules.

    

    Name of
NASD Member Firm

    
      
         

      

      
        14

        
          

        

      

      
         

      

    

    By:                                                                

    Authorized
Officer

    
      
         

      

      
        15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}]]